Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome - A population pharmacokinetic study

British Journal of Clinical Pharmacology

Volumn 51, Issue 6, 2001, Pages 557-565

  Mouly, Stéphane ^a,d   Aymard, Guy ^a   Tillement, Jean Paul ^b   Caulin, Charles ^b   Bergmann, Jean Francois ^c   Urien, Saik ^c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

CD4; Diarrhoea; HIV infection; Oral ganciclovir; Population pharmacokinetics

Indexed keywords

DIDANOSINE; GANCICLOVIR; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC DIARRHEA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HEALTH STATUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFLAMMATION; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; STATISTICS; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADMINISTRATION, ORAL; ADULT; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIARRHEA; FEMALE; GANCICLOVIR; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NUTRITIONAL STATUS; PERMEABILITY; TIME FACTORS; WEIGHT LOSS;

EID: 0034832990     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01389.x     Document Type: Article

References (31)

1. Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: A phase I/II study
2. Pharmacokinetics of oral ganciclovir alone, and in combination with zidovudine, didanosine, and probenecide in HIV-infected subject
3. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome
4. Effect of malabsorption on nutritional status and resting energy expenditure in HIV-infected patients
5. Intestinal inflammation, ileal structure and function in HIV
6. Intestinal absorptive capacity, intestinal permeability, and jejunal histology in HIV and their relation to diarrhoea
7. Intestinal absorption and permeability in human immunodeficiency virus-infected patients
8. Clinical pharmacokinetics of zidovudine: Inter and intraindividual variability and relationship to long term efficacy and toxicity
9. Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection
10. Population pharmacokinetics of rifabutin in human immunodeficiency virus-infected patients
11. Problems in pharmacokinetic investigations in patients with HIV infection
12. Population differences in ganciclovir clearance as determined by nonlinear mixed effect modeling
13. A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation
14. Pharmacokinetics of fluconazole in people with HIV infection: A population analysis
15. Premarketing observational studies of population pharmacokinetics of new drugs
16. Prediction of creatinine clearance from serum creatinine
17. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
18. Gas chromatography applied to the lactulose-mannitol intestinal permeability test
19. HPLC determination of serum ganciclovir using ultrafiltration, ultraviolet and fluorescence detection
20. Population pharmacokinetics of high dose thiopental in patients with cerebral injuries
21. Estimating impossible curves using NONMEM
22. Comparison of measured and estimated creatinine clearance in patients with advanced HIV disease
23. Zidovudine absorption and small intestinal function in HIV seropositive patients
24. Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS)
25. Gastric acid secretion in HIV-1 infection
26. Histopathologic findings of duodenal biopsy specimen in HIV-infected patients with and without diarrhoea and malabsorption
27. Ultrastructure of the jejunal mucosa in human immunodeficiency virus infection
28. Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation
29. Steady-state relative bioavailability of three oral ganciclovir dosage regimens delivering 6, 000 mg/day in patients with human immunodeficiency virus
30. +-dependent nucleoside transporter from rabbit intestine
31. The impact of HIV infection on lactose absorptive capacity